Reengineering Aligned D‐Orbital Energy Levels in FeMn Dual‐Atom Nanozyme Inhibits Pyroptosis for Effective Alleviation of Inflammatory Diseases

View at publisher
Authors: Jianfeng Guo, Xia Yang, SHIXING LUO, R. Zhang, Shuaiyi Liang, Zhengtian Li, Zhangrui Huang, Yuting Ye, Ji Luo, Zhiquan Pang, Y. C. Yu, Jinmin Zhao
+4 more Jianwei Liu, Li Zheng, Kelong Fan, Jingping Zhong
Cited by: 4
References: 40

Abstract

ABSTRACT Pyroptosis inhibition via Fe single‐atom nanozymes is promising for inflammation therapy, but the common Fe‐N 4 configuration restricts oxygen intermediate desorption and lacks cooperative sites, thus limiting catalytic performance. To overcome this, we develop a FeMn dual‐atom nanozyme supported on oxygen‐nitrogen‐doped bamboo‐like carbon nanotubes (FeMn DA /BCNT). Through the precise alignment of Fe and Mn 3 dz 2 orbital energy levels by the electron‐delocalized BCNT support in the FeMn‐N/O active center, thereby lowering the dissociation energy barrier for * O 2 or * H 2 O molecules, promoting O─O bond cleavage to bypass toxic ─OOH species, and thus accelerating the enzyme‐like kinetics. Combined with a hierarchical porous bamboo‐like structure of the BCNT that enhances high specific surface, atom exposure, and mass transfer, the FeMn DA /BCNT nanozymes exhibit potent superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx)‐like activities. Further encapsulation with a macrophage membrane ([MM]FeMn DA /BCNT) confers excellent biocompatibility and active targeting ability toward inflammatory sites. The resulting [MM]FeMn DA /BCNT nanozymes target the inflammatory microenvironment, scavenges ROS, restores mitochondrial function, and suppresses NLRP3 inflammasome activation, thereby inhibiting pyroptosis. In vivo, [MM]FeMn DA /BCNT nanozymes show good biocompatibility and efficacy in treating osteoarthritis, acute liver injury, and acute kidney injury. This work provides a novel strategy for inflammatory disease therapy using a biomimetic dual‐atom nanozyme.

Fields of Study & Subjects

Advanced Nanomaterials in Catalysis Nanoplatforms for cancer theranostics Inflammasome and immune disorders

Publication details

Journal / source
Advanced Materials
Publisher
Wiley
Volume
38
Issue
23
Pages
e72857–e72857
Publication date
25 March 2026
Language
EN